IL22 and type 2 diabetes mellitus: Recombinant IL-22 and IL-22-producing ILC3+ subpopulations reduced the bacterial burden, lung epithelial cell damage, insulin level and lipid metabolites and prolonged the survival of Mtb-infected T2DM mice.